VRTX

Vertex Pharmaceuticals
D

VRTX

Arincen81/100B

Vertex Pharmaceuticals market cap

Vertex Pharmaceuticals's market cap is 138.65B USD: 253,461,000 shares outstanding at today's price of 547.03.

Today
138.65B
Average, 5 years
114.00B
Low, 5 years
46.83B
High, 5 years
142.02B

Market cap = price × shares outstanding = 547.03 × 253.46M = 138.65B

Each day's closing price times the shares outstanding in the last 10-Q or 10-K filed by then (the quarter's basic share count, adjusted for splits); from the latest count on, the shares outstanding now.

Market cap by year and by quarter

Fiscal yearPeriod endingMarket cap
Today138.65B
FY202531 Dec 2025115.92B
FY202431 Dec 2024103.70B
FY202331 Dec 2023104.86B
FY202231 Dec 202273.96B
FY202131 Dec 202156.59B
FY202031 Dec 202061.41B
FY201931 Dec 201956.21B
FY201831 Dec 201842.14B
FY201731 Dec 201737.29B
FY201631 Dec 201617.95B
FY201531 Dec 201530.30B
FY201431 Dec 201427.91B
FY201331 Dec 201316.70B
FY201231 Dec 20128.88B
FY201131 Dec 20116.80B
FY201031 Dec 20107.02B
FY200931 Dec 20097.42B
FY200831 Dec 20084.27B
FY200731 Dec 20073.00B
FY200631 Dec 20064.24B
FY200531 Dec 20052.47B
FY200431 Dec 2004830.50M
FY200331 Dec 2003796.99M
FY200231 Dec 20021.20B
FY200131 Dec 20011.83B
FY200031 Dec 20004.84B
FY199931 Dec 1999893.13M
FY199831 Dec 1998752.65M
FY199731 Dec 1997800.71M
FY199631 Dec 1996752.34M
FY199531 Dec 1995452.18M
FY199431 Dec 1994235.71M
FY199331 Dec 1993231.25M
FY199231 Dec 1992118.39M
FY199131 Dec 1991107.79M
FY199031 Dec 199088.54M

See also:P/E ratio,P/S ratio,ROE (return on equity),Debt to equity,Current ratio,All ratios

Common questions about Vertex Pharmaceuticals's market cap

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.